Huntington, J. A., Yu, B., Li, L., Jensen, E., Bruno, C., Boakye, M., . . . Rhee, E. (2020). Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP). Antimicrob Agents Chemother.
Citação norma ChicagoHuntington, Jennifer A., et al. "Outcomes in Participants With Renal Impairment From a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP)." Antimicrob Agents Chemother 2020.
MLA CitationHuntington, Jennifer A., et al. "Outcomes in Participants With Renal Impairment From a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP)." Antimicrob Agents Chemother 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.